Cargando…

Immune gene signature delineates a subclass of thyroid cancer with unfavorable clinical outcomes

Thyroid cancer (THCA) is a heterogeneous disease with multiple clinical outcomes Immune cells regulate its progression. Three immunomolecular subtypes (C1, C2, C3) were identified in gene expression data sets from TCGA and GEO databases. Among them, subtype C3 had highest frequency of BRAF mutations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhi, Jingtai, Yi, Jiaoyu, Tian, Mengran, Wang, Huijuan, Kang, Ning, Zheng, Xiangqian, Gao, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185138/ https://www.ncbi.nlm.nih.gov/pubmed/32240105 http://dx.doi.org/10.18632/aging.102963

Ejemplares similares

Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes
por: Kim, Kyuryung, et al.
Publicado: (2018)

The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
por: Yi, Jiaoyu, et al.
Publicado: (2021)

Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib
por: Hu, Linfei, et al.
Publicado: (2022)

Functional analysis and clinical significance of the isocitrate dehydrogenase 2 gene in papillary thyroid carcinoma
por: Zhang, Jun, et al.
Publicado: (2019)

Immune‐related lncRNA signature delineates an immune‐excluded subtype of liver cancer with unfavorable clinical outcomes
por: Chen, Yawei, et al.
Publicado: (2022)

Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents
por: Huang, Dongmei, et al.
Publicado: (2022)

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma
por: Gu, Pengfei, et al.
Publicado: (2022)

Correlation between obesity and clinicopathological characteristics in patients with papillary thyroid cancer: a study of 1579 cases: a retrospective study
por: Wang, Huijuan, et al.
Publicado: (2020)

Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases
por: Zhi, Jingtai, et al.
Publicado: (2017)

To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments
por: Sun, Ying, et al.
Publicado: (2022)

Surgery and Radioactive Iodine Therapeutic Strategy for Patients Greater Than 60 Years of Age with Differentiated Thyroid Cancer
por: Tang, Tao, et al.
Publicado: (2022)

Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients
por: Zheng, Xiangqian, et al.
Publicado: (2019)

Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer
por: Ma, Weike, et al.
Publicado: (2023)

Targeting Aurora-A inhibits tumor progression and sensitizes thyroid carcinoma to Sorafenib by decreasing PFKFB3-mediated glycolysis
por: Jingtai, Zhi, et al.
Publicado: (2023)

KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway
por: Zhang, Wei, et al.
Publicado: (2022)

FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer
por: Qiu, Li, et al.
Publicado: (2020)

Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer
por: Zhang, Jun, et al.
Publicado: (2021)

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway
por: Meng, Xiangrui, et al.
Publicado: (2020)

On a Subclass of Meromorphic Close-to-Convex Functions
por: Li, Ming-Liang, et al.
Publicado: (2014)

Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, Daniel, et al.
Publicado: (2013)

Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer
por: Christinat, Yann, et al.
Publicado: (2015)

Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer
por: Xie, Wenjun, et al.
Publicado: (2021)

Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer
por: Zeng, Yu, et al.
Publicado: (2023)

Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection
por: Singh, Amit Kumar, et al.
Publicado: (2020)

The dynamic history of plastome structure across aquatic subclass Alismatidae
por: Li, Zhi-Zhong, et al.
Publicado: (2023)

Consistent analysis of differentially expressed genes across 7 cell types in papillary thyroid carcinoma
por: Ruan, Xianhui, et al.
Publicado: (2023)

Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
por: Gao, Xingxing, et al.
Publicado: (2021)

Bioinformatics identification and validation of aging‑related molecular subtype and prognostic signature in breast cancer
por: Li, Jingtai, et al.
Publicado: (2023)

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer
por: Miller, Lance D, et al.
Publicado: (2014)

PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause
por: Hou, Xiukun, et al.
Publicado: (2023)

Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature
por: Watanabe, Tsubasa, et al.
Publicado: (2020)

Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis
por: Huang, Dongmei, et al.
Publicado: (2022)

IgG subclass deposition in diabetic nephropathy
por: Tang, Xuanli, et al.
Publicado: (2022)

Relationship between subclasses low-density lipoprotein and carotid plaque
por: Pan, Zhanhai, et al.
Publicado: (2022)

High-dimensional Single-cell Analysis Delineates Peripheral Immune Signature of Coronary Atherosclerosis in Human Blood
por: Fan, Lin, et al.
Publicado: (2022)

Subclassing and hooking with Visual Basic
por: Teilhet, Stephen
Publicado: (2001)

Subclass Changes in Fibrillary Glomerulonephritis
por: Biederman, Laura E., et al.
Publicado: (2022)

Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease
por: Niang, Fatoumata, et al.
Publicado: (2015)

Delineation of metabolic gene clusters in plant genomes by chromatin signatures
por: Yu, Nan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_on4vo3e6hkc0lcc99vdckv6ifq